Last reviewed · How we verify

NCT07364097: DECIBEL

A Study of Silent Alarm Delivery Versus Standard Audible Alarm Delivery in Intensive Care and High Dependency Units

Active, enrolled NA Last updated 6 February 2026
What this trial tests

NA trial testing Silent alarm strategy in Delirium in the Intensive Care Unit in 200 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
3 February 2026
Primary endpoint
28 April 2026
28 April 2026

Quick facts

Lead sponsorMindWave Medical Inc
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposeprevention
Enrollment200
Start date3 February 2026
Primary completion28 April 2026
Estimated completion28 April 2026
Sites1 location across India

Drugs / interventions tested

Conditions studied

Sponsor

MindWave Medical Inc

Who can join

18 and older, any sex, with Delirium in the Intensive Care Unit or Burnout, Healthcare Workers. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of the trial is to learn if a strategy to eliminate audible alarm noise in intensive care and high dependency units can reduce overall noise levels, patient delirium, staff alarm fatigue, and staff burnout. Researchers will implement a silent alarm strategy in specific care units for four weeks and compare this to a separate 4 weeks where a silent strategy is not implemented. Noise, burnout, delirium levels, and staff alarm response times will be compared between the silent and non-silent units.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Delirium in the Intensive Care Unit

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07364097.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing